Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypercholesterolemia: HELP
Evan A. Stein
Based on 25 articles published since 2010
(Why 25 articles?)
||||
Expertise Level
The expertise of Evan A. Stein ranks in the
  • Top 0.041%
  • ... of 31,653 published authors worldwide on Hypercholesterolemia
  • ... from 2010 through 2020
  • ... based on contributions to 25 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Stein, Evan A   ·   Stein, Evan
Work Locations
Details
Most likely:    University of Chicago   Contact    
2020
  • Lipid Clinic Heart Institute (InCor), University of São Paulo Medical School Hospital and Hospital Israelita Albert Einstein, São Paulo, Brazil. Electronic address: · Department of Medicine, Cardiology, University of Chicago Pritzker School of Medicine, Chicago, Illinois. · Department of Vascular Medicine, Amsterdam UMC, Location AMC, Amsterdam, the Netherlands. · Division of Lipidology and Hatter Institute for Cardiovascular Research in Africa, Department of Medicine, University of Cape Town, Cape Town, South Africa. · Cardiovascular Trials Unit, Manchester University Hospital NHS Foundation Trust, Manchester, United Kingdom. · School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia, Australia; Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, Perth, Western Australia, Australia. · Amgen, Thousand Oaks, California. · Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa. · Pubmed 32057369
Probable:    Miscellaneous institutions in Cincinnati      
2018
  • Departments of Vascular Medicine (D.M.K., M.J.A.M.B., J.J.P.K.). · Pediatrics (D.M.K., M.J.A.M.B., A.W.). · Lipid Clinic, Medical Department, Oslo University Hospital, Norway (G.C.). · Department of Pediatrics, University of Toronto, Labatt Family Health Center, The Hospital for Sick Children, Canada (B.W.C.). · Department of Hepatology and Metabolic Center, University Hospitals Leuven, Belgium (D.C.). · Healthy Heart Program Prevention Clinic, St. Paul's Hospital, Vancouver, Canada (G.A.F.). · Department of Medicine, University of British Columbia, Vancouver, Canada (G.A.F.). · Clinique des Maladies Lipidiques de Québec Inc, Canada (C.G.). · Department of Medicine, Université de Montréal, Canada (D.G.). · Department of Pediatrics, McMaster University, Hamilton, Canada (K.M.M.). · Metabolic & Atherosclerosis Research Center, Cincinnati, OH (T.T., E.A.S.). · AstraZeneca Pharmaceuticals LP, Wilmington, DE (E.M., J.R.). · AstraZeneca, Macclesfield, UK (P.D.M.). · Clinical Epidemiology, Biostatistics and Bioinformatics (B.A.H.), Academic Medical Center, Amsterdam, the Netherlands. · Pubmed 29431667
2017
  • Department of Medical Biotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. · Department of Medical Biotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; Nanotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. · Department of Hypertension, WAM University Hospital in Lodz, Medical University of Lodz, Zeromskiego 113, Lodz, Poland; Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland. · Wihuri Research Institute, Helsinki, Finland. · Metabolic and Atherosclerosis Research Center, Cincinnati, OH, USA. · Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran. Electronic address: · Pubmed 28506805
  • From Department of Vascular Medicine (M.J.A.M.B., D.M.K., J.J.P.K.), Department of Pediatrics (M.J.A.M.B., A.W.), and Department of Clinical Epidemiology, Biostatistics and Bioinformatics (B.A.H.), Academic Medical Center, Amsterdam, the Netherlands · Lipid Clinic, Medical Department, Oslo University Hospital, Norway (G.L.) · Department of Pediatrics, University of Toronto, Labatt Family Health Center, The Hospital for Sick Children, Ontario, Canada (B.W.M.) · Department of Hepatology and Metabolic Center, University Hospitals Leuven, Belgium (D.C.) · Healthy Heart Program Prevention Clinic, St. Paul's Hospital, Vancouver, British Columbia, Canada (G.A.F.) · Department of Medicine, University of British Columbia, Vancouver, Canada (G.A.F.) · Clinique des Maladies Lipidiques de Québec Inc, Québec, QC, Canada (C.G.) · Department of Medicine, Université de Montréal, Montréal, Québec, Canada (D.G.) · Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada (K.M.M.) · Metabolic & Atherosclerosis Research Center, Cincinnati, OH (T.T., E.A.S.) · AstraZeneca Pharmaceuticals LP, Wilmington, DE (E.M., J.S.R.) · and AstraZeneca, Macclesfield, Cheshire, United Kingdom (P.D.M.). · Pubmed 28592434
2016
  • Metabolic and Atherosclerosis Research Center, Cincinnati, OH, USA. · Pubmed 27669716
  • Metabolic & Atherosclerosis Research Center, Cincinnati, OH. · Louisville Metabolic & Atherosclerotic Research Center, Louisville, KY. · Jacksonville Center for Clinical Research, Jacksonville, FL. · Gemphire Therapeutics Inc., Northville, MI. · Gemphire Therapeutics Inc., Northville, MI. Electronic address: · Pubmed 27678439
  • Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio. · Department of Clinical Development, and Biostatistics, Amgen Inc., Thousand Oaks, California. · The Cardiometabolic Disorders Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, Netherlands. · Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom. · Clinical Trial Service Unit and Epidemiological Services Unit, University of Oxford, Oxford, United Kingdom. · Department of Medicine, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medicine, Baylor College of Medicine and Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, Texas. · Department of Pharmacological Sciences, University of Milan, and IRCCS Multimedica, Milan, Italy. · Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany. · Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio. · Department of Cardiology, Hartford Hospital, Hartford, Connecticut. · Pubmed 26946077
  • Cleveland Clinic, Cleveland, Ohio. · University of Amsterdam Faculty of Medicine, Amsterdam, the Netherlands. · Amgen Inc, Thousand Oaks, California. · School of Medicine at Mount Sinai, New York, New York. · Flinders University, Bedford Park, SA, Australia. · University of Glasgow, Glasgow, United Kingdom. · Clinical Trial Service Unit, University of Oxford, Oxford, United Kingdom8Epidemiological Services Unit, University of Oxford, Oxford, United Kingdom. · University Hospital of Paris 6, Paris, France. · Charles University in Prague, Prague, Czech Republic11General University Hospital in Prague, Prague, Czech Republic. · David Geffen School of Medicine at the University of California, Los Angeles. · Baylor College of Medicine, Houston, Texas. · Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany. · Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio. · Pubmed 27039291
2015
  • Metabolic & Atherosclerosis Research Center, Cincinnati, Ohio. · Metabolic & Atherosclerosis Research Center, Cincinnati, Ohio. Electronic address: · Pubmed 26548322
  • Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands; Department of Pediatrics, Academic Medical Center, Amsterdam, The Netherlands. Electronic address: · Lipid Clinic, Oslo University Hospital, Oslo, Norway. Electronic address: · Department of Pediatrics, Labatt Family Health Center, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada. · Department of Hepatology and Metabolic Center, University Hospitals Leuven, Leuven, Belgium. · Department of Medicine, Healthy Heart Program Prevention Clinic, University of British Columbia, Vancouver, BC, Canada. · Clinique des Maladies Lipidiques de Québec, Québec, QC, Canada. · Department of Medicine, Université de Montréal, Chicoutimi, QC, Canada. · Department of Pediatrics, McMaster University, Hamilton, ON, Canada. · Department of Pediatrics, Academic Medical Center, Amsterdam, The Netherlands. · Metabolic & Atherosclerosis Research Center, Cincinnati, OH, USA. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands; Department of Pediatrics, Academic Medical Center, Amsterdam, The Netherlands. · Department of Research and Development, AstraZeneca LP, Wilmington, DE, USA. · Department of Biometrics and Information Sciences, AstraZeneca, Mölndal, Sweden. · Department of Pharmacology, AstraZeneca, Macclesfield, Cheshire, UK. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. · Pubmed 26687694
  • From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and the Department of Medicine, Harvard Medical School, Boston (M.S.S., R.P.G., S.D.W.) · the Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg (F.J.R.), and the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town (D.J.B.) - both in South Africa · the Departments of Epidemiology and Medicine, College of Public Health, University of Iowa, Iowa City (J.R.) · the Sections of Cardiovascular Research and Cardiology, Department of Medicine, Baylor College of Medicine, and the Center for Cardiovascular Disease Prevention, Houston Methodist DeBakey Heart and Vascular Center, Houston (C.M.B.) · Amgen, Thousand Oaks, CA (R. Somaratne, J.L., S.M.W., R. Scott) · Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.) · and the Metabolic and Atherosclerosis Research Center, Cincinnati (E.A.S.). · Pubmed 25773607
2013
  • Metabolic and Atherosclerosis Research Center, Cincinnati, OH (E.A.S.) · Global Development (N.H., S.M.W., R.S.) and Biostatistics (F.X.), Amgen Inc, Thousand Oaks, CA · and Carbohydrate & Lipid Metabolism Research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa (F.J.R.). · Pubmed 24014831
2011
  • Metabolic and Atherosclerosis Research Center, Cincinnati, OH 45212, USA. · Pubmed 21518985
2012
Probable:    University of Cincinnati   Contact    
2014
  • Department of Pathology & Laboratory Medicine, University of Cincinnati, Cincinnati, Ohio 45215; email: · Pubmed 24422577
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 25 total) written by Evan A. Stein about Hypercholesterolemia:

  • Long-Term Evolocumab in Patients With Familial Hypercholesterolemia. 2020
  • Response by Kusters et al to Letter Regarding Article, "Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)". 2018
  • HDL abnormalities in familial hypercholesterolemia: Focus on biological functions. 2017
  • Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label). 2017
  • PCSK9: the Critical Role of Familial Hypercholesterolemia from Discovery to Benefit for all : Editorial to: "Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/Dl or Higher" by Henry N. Ginsberg et Al. 2016
  • Efficacy and safety of gemcabene as add-on to stable statin therapy in hypercholesterolemic patients. 2016
  • Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial. 2016
  • Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial. 2016
  • Non-statin Treatments for Managing LDL Cholesterol and Their Outcomes. 2015
  • Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON study. 2015
Show List of Full Article Records
Google Searches

Learn more about Evan A. Stein using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Chicago
Miscellaneous institutions in Cincinnati
University of Cincinnati
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Chicago
2020
  • Lipid Clinic Heart Institute (InCor), University of São Paulo Medical School Hospital and Hospital Israelita Albert Einstein, São Paulo, Brazil. Electronic address: · Department of Medicine, Cardiology, University of Chicago Pritzker School of Medicine, Chicago, Illinois. · Department of Vascular Medicine, Amsterdam UMC, Location AMC, Amsterdam, the Netherlands. · Division of Lipidology and Hatter Institute for Cardiovascular Research in Africa, Department of Medicine, University of Cape Town, Cape Town, South Africa. · Cardiovascular Trials Unit, Manchester University Hospital NHS Foundation Trust, Manchester, United Kingdom. · School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia, Australia; Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, Perth, Western Australia, Australia. · Amgen, Thousand Oaks, California. · Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa. · Pubmed 32057369
Miscellaneous institutions in Cincinnati
2018
  • Departments of Vascular Medicine (D.M.K., M.J.A.M.B., J.J.P.K.). · Pediatrics (D.M.K., M.J.A.M.B., A.W.). · Lipid Clinic, Medical Department, Oslo University Hospital, Norway (G.C.). · Department of Pediatrics, University of Toronto, Labatt Family Health Center, The Hospital for Sick Children, Canada (B.W.C.). · Department of Hepatology and Metabolic Center, University Hospitals Leuven, Belgium (D.C.). · Healthy Heart Program Prevention Clinic, St. Paul's Hospital, Vancouver, Canada (G.A.F.). · Department of Medicine, University of British Columbia, Vancouver, Canada (G.A.F.). · Clinique des Maladies Lipidiques de Québec Inc, Canada (C.G.). · Department of Medicine, Université de Montréal, Canada (D.G.). · Department of Pediatrics, McMaster University, Hamilton, Canada (K.M.M.). · Metabolic & Atherosclerosis Research Center, Cincinnati, OH (T.T., E.A.S.). · AstraZeneca Pharmaceuticals LP, Wilmington, DE (E.M., J.R.). · AstraZeneca, Macclesfield, UK (P.D.M.). · Clinical Epidemiology, Biostatistics and Bioinformatics (B.A.H.), Academic Medical Center, Amsterdam, the Netherlands. · Pubmed 29431667
2017
  • Department of Medical Biotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. · Department of Medical Biotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; Nanotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. · Department of Hypertension, WAM University Hospital in Lodz, Medical University of Lodz, Zeromskiego 113, Lodz, Poland; Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland. · Wihuri Research Institute, Helsinki, Finland. · Metabolic and Atherosclerosis Research Center, Cincinnati, OH, USA. · Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran. Electronic address: · Pubmed 28506805
  • From Department of Vascular Medicine (M.J.A.M.B., D.M.K., J.J.P.K.), Department of Pediatrics (M.J.A.M.B., A.W.), and Department of Clinical Epidemiology, Biostatistics and Bioinformatics (B.A.H.), Academic Medical Center, Amsterdam, the Netherlands · Lipid Clinic, Medical Department, Oslo University Hospital, Norway (G.L.) · Department of Pediatrics, University of Toronto, Labatt Family Health Center, The Hospital for Sick Children, Ontario, Canada (B.W.M.) · Department of Hepatology and Metabolic Center, University Hospitals Leuven, Belgium (D.C.) · Healthy Heart Program Prevention Clinic, St. Paul's Hospital, Vancouver, British Columbia, Canada (G.A.F.) · Department of Medicine, University of British Columbia, Vancouver, Canada (G.A.F.) · Clinique des Maladies Lipidiques de Québec Inc, Québec, QC, Canada (C.G.) · Department of Medicine, Université de Montréal, Montréal, Québec, Canada (D.G.) · Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada (K.M.M.) · Metabolic & Atherosclerosis Research Center, Cincinnati, OH (T.T., E.A.S.) · AstraZeneca Pharmaceuticals LP, Wilmington, DE (E.M., J.S.R.) · and AstraZeneca, Macclesfield, Cheshire, United Kingdom (P.D.M.). · Pubmed 28592434
2016
  • Metabolic and Atherosclerosis Research Center, Cincinnati, OH, USA. · Pubmed 27669716
  • Metabolic & Atherosclerosis Research Center, Cincinnati, OH. · Louisville Metabolic & Atherosclerotic Research Center, Louisville, KY. · Jacksonville Center for Clinical Research, Jacksonville, FL. · Gemphire Therapeutics Inc., Northville, MI. · Gemphire Therapeutics Inc., Northville, MI. Electronic address: · Pubmed 27678439
  • Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio. · Department of Clinical Development, and Biostatistics, Amgen Inc., Thousand Oaks, California. · The Cardiometabolic Disorders Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, Netherlands. · Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom. · Clinical Trial Service Unit and Epidemiological Services Unit, University of Oxford, Oxford, United Kingdom. · Department of Medicine, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medicine, Baylor College of Medicine and Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, Texas. · Department of Pharmacological Sciences, University of Milan, and IRCCS Multimedica, Milan, Italy. · Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany. · Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio. · Department of Cardiology, Hartford Hospital, Hartford, Connecticut. · Pubmed 26946077
  • Cleveland Clinic, Cleveland, Ohio. · University of Amsterdam Faculty of Medicine, Amsterdam, the Netherlands. · Amgen Inc, Thousand Oaks, California. · School of Medicine at Mount Sinai, New York, New York. · Flinders University, Bedford Park, SA, Australia. · University of Glasgow, Glasgow, United Kingdom. · Clinical Trial Service Unit, University of Oxford, Oxford, United Kingdom8Epidemiological Services Unit, University of Oxford, Oxford, United Kingdom. · University Hospital of Paris 6, Paris, France. · Charles University in Prague, Prague, Czech Republic11General University Hospital in Prague, Prague, Czech Republic. · David Geffen School of Medicine at the University of California, Los Angeles. · Baylor College of Medicine, Houston, Texas. · Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany. · Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio. · Pubmed 27039291
2015
  • Metabolic & Atherosclerosis Research Center, Cincinnati, Ohio. · Metabolic & Atherosclerosis Research Center, Cincinnati, Ohio. Electronic address: · Pubmed 26548322
  • Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands; Department of Pediatrics, Academic Medical Center, Amsterdam, The Netherlands. Electronic address: · Lipid Clinic, Oslo University Hospital, Oslo, Norway. Electronic address: · Department of Pediatrics, Labatt Family Health Center, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada. · Department of Hepatology and Metabolic Center, University Hospitals Leuven, Leuven, Belgium. · Department of Medicine, Healthy Heart Program Prevention Clinic, University of British Columbia, Vancouver, BC, Canada. · Clinique des Maladies Lipidiques de Québec, Québec, QC, Canada. · Department of Medicine, Université de Montréal, Chicoutimi, QC, Canada. · Department of Pediatrics, McMaster University, Hamilton, ON, Canada. · Department of Pediatrics, Academic Medical Center, Amsterdam, The Netherlands. · Metabolic & Atherosclerosis Research Center, Cincinnati, OH, USA. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands; Department of Pediatrics, Academic Medical Center, Amsterdam, The Netherlands. · Department of Research and Development, AstraZeneca LP, Wilmington, DE, USA. · Department of Biometrics and Information Sciences, AstraZeneca, Mölndal, Sweden. · Department of Pharmacology, AstraZeneca, Macclesfield, Cheshire, UK. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. · Pubmed 26687694
  • From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and the Department of Medicine, Harvard Medical School, Boston (M.S.S., R.P.G., S.D.W.) · the Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg (F.J.R.), and the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town (D.J.B.) - both in South Africa · the Departments of Epidemiology and Medicine, College of Public Health, University of Iowa, Iowa City (J.R.) · the Sections of Cardiovascular Research and Cardiology, Department of Medicine, Baylor College of Medicine, and the Center for Cardiovascular Disease Prevention, Houston Methodist DeBakey Heart and Vascular Center, Houston (C.M.B.) · Amgen, Thousand Oaks, CA (R. Somaratne, J.L., S.M.W., R. Scott) · Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.) · and the Metabolic and Atherosclerosis Research Center, Cincinnati (E.A.S.). · Pubmed 25773607
2013
  • Metabolic and Atherosclerosis Research Center, Cincinnati, OH (E.A.S.) · Global Development (N.H., S.M.W., R.S.) and Biostatistics (F.X.), Amgen Inc, Thousand Oaks, CA · and Carbohydrate & Lipid Metabolism Research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa (F.J.R.). · Pubmed 24014831
2011
  • Metabolic and Atherosclerosis Research Center, Cincinnati, OH 45212, USA. · Pubmed 21518985
2012
University of Cincinnati
2014
  • Department of Pathology & Laboratory Medicine, University of Cincinnati, Cincinnati, Ohio 45215; email: · Pubmed 24422577
Medpace Reference Laboratories
2013
  • Metabolic & Atherosclerosis Research Center and Medpace Reference Laboratories, 5355 Medpace Way, Cincinnati, OH, USA. · Pubmed 23371064
2012
  • Medpace Reference Laboratories, Inc, 4620 Wesley Avenue, Cincinnati, OH 45212, USA. · Pubmed 22304793
Miscellaneous cities in Ohio
2012
  • Metabolic and Atherosclerosis Research Center, 4685 Forest Ave., Cincinnati, OH 45212, USA. · Pubmed 22435370
6 Other Locations Show
Yearly article counts 10124412622
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.